CAS 260553-97-7

TM-25659

CAS : 260553-97-7

Formule : C₃₀H₂₈N₈

Degré de pureté : 98%

Masse moléculaire : 500.5969

Ref: IN-DA01FT64

3-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-2-Butyl-5-Methyl-6-(Pyridin-3-Yl)-3H-Imidazo[4,5-B]Pyridine

CAS : 260553-97-7

3-((2'-(1H-Tetrazol-5-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-2-Butyl-5-Methyl-6-(Pyridin-3-Yl)-3H-Imidazo[4,5-B]Pyridine

Degré de pureté : 98%

Masse moléculaire : 500.6g/mol

Ref: 54-OR1023112

TM-25659

CAS : 260553-97-7

TM-25659

Degré de pureté : ≥90%

Masse moléculaire : 500.6g/mol

Ref: 54-BUP02023

TM-25659

CAS : 260553-97-7

TM-25659 is a small molecule that inhibits the growth of cancer cells by interfering with signal pathways in the cell. TM-25659 has been shown to inhibit the localization of fetal bovine serum (FBS) in osteogenic genes, which may be due to its effect on growth factor-β1. This drug also has an inhibitory effect on the polymerase chain reaction (PCR), which is important for gene expression regulation. TM-25659 binds to monoclonal antibodies that are specific for growth factors, inactivating them and preventing their binding to receptors on the surface of cells, thus inhibiting their effects. In addition, TM-25659 has anti-inflammatory properties and can be used as a treatment for rheumatoid arthritis or other inflammatory diseases.

Formule : C₃₀H₂₈N₈

Degré de pureté : Min. 95%

Masse moléculaire : 500.6 g/mol

Ref: 3D-KKA55397

TM-25659

CAS : 260553-97-7

TM-25659 is a modulator of transcriptional co-activator with PDZ-binding motif (TAZ), with anti-osteoporotic and anti-obesity activities.

Formule : C₃₀H₂₈N₈

Degré de pureté : 99.63%

Couleur et forme : Solid

Masse moléculaire : 500.6

Ref: TM-T13169